1 |
Al-Azzawi F. 2008. Prevention of postmenopausal osteoporosis and associated fractures: Clinical evaluation of the choice between estrogen and bisphosphonates. Gynecol. Endocrinol. 24:601-609.
DOI
|
2 |
Arlot, M. C., Meunier, P. J. and Chavassieux, P. 1995. Effects of long-term alendronate treatment for postmenopausal osteoporosis on bone histomorphometry. J. Bone Miner. Res. 10:1:S199.
|
3 |
Aubin, J. E. 2001. Regulation of osteoblast formation and function. Rev. Endocr. Metab. Disord. 2:81-94.
DOI
|
4 |
Axelrod, D. W. and Teitelbaum, S. L. 1994. Results of long-term cyclical etidronate therapy: Bone histomorphometry and clinical correlates. J. Bone Miner. Res. 9:1:S136.
|
5 |
Balena, R., Toolan, B. C., Shea, M., Markatos, A., Myers, E. R., Lee, S. C., Opas, E. E., Seedor, J. G., Klein, H., Frankenfield, D., Quartuccio, H., Fioravanti, C., Clair, J., Brown, E., Hayes, W. C. and Rodan, G. A. 1993. The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates. J. Clin. Invest. 92:2577-2586.
DOI
|
6 |
Bennett, C. N., Longo, K. A., Wright, W. S., Suva, L. J., Lane, T. F., Hankenson, K. D. and MacDougald O. A. 2005. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc. Natl. Acad. Sci. 102:3324-3329.
DOI
|
7 |
Cashman, K. D. 2007. Diet, nutrition, and bone health. J. Nutr. 137:2507S-2512S.
DOI
|
8 |
Cornish, J. 2004. Lactoferrin promotes bone growth. BioMetals. 17:331-335.
DOI
|
9 |
Dane, C., Dane, B., Cetin, A. and Erginbas, M. 2008. Effect of risedronate on biochemical marker of bone resorption in postmenopausal women with osteoporosis or osteopenia. Gynecol. Endocrinol. 24:207-213.
DOI
|
10 |
Danone. 2001. Fermented foods and healthy digestive functions. France: Danone Publications, John Libbey Euro text.
|
11 |
Davis, S., Oliver, A., Goeckeritz, B. and Sachdeva, A. 2010. All about osteoporosis: A comprehensive analysis. J. Muscoskel. Med. 27:149-153.
|
12 |
Deeth, H. C. and Tamime, A. Y. 1981. Yogurt, nutritive and therapeutic aspects. J. Food Prot. 44:78-86.
DOI
|
13 |
Fernandes, C. F., Shahani, K. M. and Amer, M. A. 1987. Therapeutic role of dietary lactobacilli and lactobacillic fermented dairy products. FEMS Microbiol. Rev. 46:343-356.
DOI
|
14 |
Dekker, J., Collett, M., Prasad, J. and Gopal, P. 2007. Functionality of probiotics potential for product development. Forum Nutr. 60:196-208.
|
15 |
Ebeling, P. R. 2008. Clinical practice. Osteoporosis in men. N. Engl. J. Med. 358:1474-1482.
DOI
|
16 |
Falk, P. G., Hooper, L. V., Midtvedt, T. and Gordon, J. F. 1998. Creating and maintaining the gastrointestinal ecosystem: what we know and need to know from gnotobiology. Microbiol. Mol. Biol. Rev. 62:1157-1170.
|
17 |
Fleisch, H. 1991. Bisphosphonates: Pharmacology and use in the treatment of tumor-induced hypercalcaemic and metastatic bone disease. Drugs. 42:919-944.
DOI
|
18 |
Frei, P., Fried, M., Hungerbuhler, V., Rammert, C., Rousson, V. and Kullak-Ublick, G. A. 2006. Analysis of risk factors for low bone mineral density in inflammatory bowel disease. Digestion 73:40-46.
DOI
|
19 |
Garnero, P., Shih, W. J., Gineyts, E., Karpf, D. B. and Delmas, P. D. 1994. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment. J. Clin. Endocrinol. Metab. 79:1693-1700.
|
20 |
Fujiwara, S., Hashiba, H., Hirota, T. and Forstner, J. F. 1997. Proteinaceous factor(s) in culture supernatant fluids of Bifidobacteria which prevents the binding of enterotoxigenic Escherichia coli to gangliotetraosylceramide. Appl. Environ. Microbiol. 63:506-512.
|
21 |
Gill, H. S. and Guarner, F. 2004. Probiotics and human health: A clinical perspective. Postgrad. Med. J. 80:516-526.
DOI
|
22 |
Iotsoval, V., Caamanol, J., Loy, J., Yang, Y., Lewin, A. and Bravo, R. 1997. Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat. Med. 3:1285-1299.
DOI
|
23 |
Gilliland, S. E. 1990. Health and nutritional benefits from lactic acid bacteria. FEMS Microbiol. Rev. 87:175-188.
DOI
|
24 |
Guy, J. A., Shea, M., Peter, C. P., Morrissey, R. and Hayes, W. C. 1993. Continuous alendronate treatment throughout growth, maturation, and aging in the rat results in increases in bone mass and mechanical properties. Calcif Tissue Int. 53:283-288.
DOI
|
25 |
Harada, S. and Rodan, G. A. 2003. Control of osteoblast function and regulation of bone mass. Nature 423:349-355.
DOI
|
26 |
Jensen, R. G., Ferris, A. M. and Lammi-Keefe, C. J. 1991. The composition of milk fat. J. Dairy Sci. 74:3228-3243.
DOI
|
27 |
Kato, K., Toba, Y. and Matsuyama, H. 2000. Milk basic protein enhances the bone strength in ovariectomized rats. J. Food Biochem. 24:467-476.
DOI
|
28 |
Lawrence, G. R. 2005. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J. Clin. Invest. 115:3318-3325.
DOI
|
29 |
Loget, F., Clough, J., Oliveira, M., Daury, M. C., Sabokbar, A. and Offord, E. 2002. Lactoferrin reduces in vitro osteoclast differentiation and resorbing activity. Biochem. Biophys. Res. Commun. 296:261-266.
DOI
|
30 |
Lee, Y. K., Nomoto, K., Salminen, S. and Gorbach, S. L. 1999. Handbook of probiotics. New York: John Wiley & Sons.
|
31 |
Narva, M., Collin, M., Lamberg-Allardt, C., Karkkainen, M., Poussa, T., Vapaatalo, H. and Korpela, R. 2004. Effects of long-term intervention with Lactobacillus helviticus-fermented milk on bone mineral density and bone mineral content in growing rats. Ann. Nut. Metabol. 48:228-234.
DOI
|
32 |
Marcus, R. 1993. Cyclic etidronate: Has the rose lost its bloom? Am. J. Med. 95:555-556.
DOI
|
33 |
Marshall, K. 2004. Therapeutic applications of whey protein. Altern. Med. Rev. 9:136-156.
|
34 |
Nakamura, Y., Yamamoto, N., Sakai, K., Okubo, A., Yamazaki, S. and Takano, T. 1995. Purified and characterization of angiotensin I-converting enzyme inhibitors form sour milk. J. Dairy Sci. 78:777-783.
DOI
|
35 |
Ohta, H., Komukai, S., Makita, K., Masuzawa, T. and Nozawa, S. 1999. Effects of 1-year ipriflavone treatment on lumbar bone mineral density and bone metabolic markers in postmenopausal women with low bone mass. Horm Res. 51:178-183.
|
36 |
Pehrsson, P. R., Haytowitz, D. B., Holden, J. M., Perry, C. R. and Beckler, D. G. 2000. USDA's National food and nutrient analysis program: Food sampling. J. Food Compos. Anal. 13:379-389.
DOI
|
37 |
Raisz, L. G. 2005. Pathogenesis of osteoporosis: Concepts, conflicts, and prospects. J. Clin. Invest. 115:3318-3325.
DOI
|
38 |
Riggs, B. L., Khosla, S. and Melton, L. J. III. 2001. The type I/type II model for involutional osteoporosis. Osteoporosis. Academic Press, San Diego.
|
39 |
Sahota, O. 2010. Reducing the risk of fractures with calcium and vitamin D. BMJ. 340:b5492.
DOI
|
40 |
Saarela, M., Lahteenmaki, L., Crittenden, R., Salminen, S., Mattila-Sandholm, T. 2002. Gut bacteria and health foods-the European perspective. Int. J. Food Microbiol. 78: 99-117.
DOI
|
41 |
Salminen, S., Wright, A. V. and Ouwehand, A. 2004. Lactic acid bacteria, microbiological and functional aspects. New York, NY.
|
42 |
Schenk, R., Eggli, P., Fleisch, H. and Rosini, S. 1986. Quantitative morphometric evaluation of the inhibitory activity of new minobisphosphonates on bone resorption in the rat. Calcif Tissue Int. 38:342-349.
DOI
|
43 |
Shinoda, H., Adamek, G., Felix, R., Fleisch, H., Schenk, R. and Hagan, P. 1983. Structureactivity relationships of various bisphosphonates. Calcif Tissue Int. 35:87-99.
DOI
|
44 |
Silvennoinen, J. A., Karttunen, T. J., Niemela, S. E., Manelius, J. J and Lehtola, J. K. 1995. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut. 37:71-76.
DOI
|
45 |
Silverwood, B. 2003. Building healthy bones. Paediatr Nurs. 15:27-29.
DOI
|
46 |
Sipola, M., Finckenberg, P., Korpela, R., Vapaatalo, H. and Nurminen, M-L. 2002. Effect of long-term intake of milk products on blood pressure in hypertensive rats. J. Dairy Res. 69:103-111.
|
47 |
Sprague, S. M. 2000. Mechanism of transplantation-asscociated bone loss. Pediatr Nephrol. 14:650-653.
DOI
|
48 |
Takada, Y., Kobayashin, N., Kato, K., Matsuyama, H., Yahiro, M. and Aoe, S. 1997b. Effects of whey protein on calcium and bone metabolism in ovariectomized rats. J. Nut. Sci. Vitaminol. 43:199-210.
DOI
|
49 |
Tang, B. M., Eslick, G. D., Nowson, C,, Smith, C. and Bensoussan, A. 2007. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: A meta-analysis. Lancet. 370:657-666.
DOI
|
50 |
Takada, Y., Kobayashin, N., Matsuyama, H., Kato, K., Yamamura, J., Yahiro, M., Kumegawa, M. and Aoe, S. 1997a. Whey protein suppresses the osteoclast mediated bone reseption and osteoclast cell formation. Int. Dairy J. 7:821-825.
DOI
|
51 |
Tannock, G. W. 1998. Studies of the intestinal microflora: A prerequisite for the development of probiotics. Int. Dairy. J. 8:527-533.
DOI
|
52 |
Tannock, G. W. 1999. A fresh look at the intestinal microflora. In Probiotics: A critical review. Edited by Tannock GW. Norfolk, UK: Horizon Scientific Press. 5-14.
|
53 |
Taranto, M. P., Medici, M., Perdigon, G., Ruiz Holgado, A. P. and Valdez, G. F. 1998. Evidence for hypocholesterolemic effect of Lactobacillus reuteri in hypercholesterolemic mice. J. Dairy Sci. 81:2336-2340.
DOI
|
54 |
Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science. 289:1504-1508.
DOI
|
55 |
The DIPART (vitamin D Individual Patient Analysis of Randomized Trials) Group, 2010. Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe. BMJ. 340, b5463.
DOI
|
56 |
Tilg, H., Moschen, A. R., Kaser, A., Pines, A. and Dotan, I. 2008. Gut, inflammation and osteoporosis: Basic and clinical concepts. Gut. 57:684-694.
DOI
|
57 |
Toba, Y., Takada, Y., Yamamura, J., Tanaka, M., Matsuoka, Y., Kawakami, H., Itabashi, A., Aoe, S. and Kumegawa, M. 2000. Milk basic protein: A novel protective function of milk against osteoporosis. Bone 27:403-408.
DOI
|
58 |
Weber, P. 1999. The role of vitamins in the prevention of osteoporosis a brief status report. Int. J. Vitam. Nutr. Res. 69:194-197.
DOI
|
59 |
Vitamin D and Calcium Supplementation to Prevent Cancer and Osteoporotic Fractures in Adults: U.S. Preventive Services Task Force Recommendation Statement. United States Preventative Task Force. 2012.
|
60 |
Walsh, M. C., Kim, N., Kadono, Y., Rho, J., Lee, S. Y., Lorenzo, J. and Choi, Y. 2006. Osteoimmunology: Interplay between the immune system and bone metabolism. Annu. Rev. Immunol. 24:33-63.
DOI
|
61 |
Ylikorkala, O. 2008. A more active role for gynecologists in the prevention of postmenopausal osteoporosis. Gynecol Endocrinol. 24:293-394.
DOI
|